Skip to content 
AMM 175: Exosomal Liquid Laser Transforming Skin in 6 Days
August 20, 2024
In this episode, listeners will learn about the latest advancements in aesthetic medicine presented at the 22nd Aesthetic & Anti-Aging Medicine World Congress in Monaco. Dr. Maria Fedchuk introduced EXOSOMAL LIQUID LASER technology, a novel treatment combining acids, microneedling, and exosomes for significant skin improvement. With over 18 years of experience, Dr. Fedchuk’s contributions, including the award-winning PEELING SYSTEM, have made notable impacts in the field. The episode also highlights how Medical Tech Systems US is bringing these innovations to the American market with a strong focus on patient safety and FDA-approved technologies.
Quick Takes
- Introduction of EXOSOMAL LIQUID LASER technology at 22nd Aesthetic & Anti-Aging Medicine World Congress
- Exosome-based treatment protocol for skin transformation in six days
- Dr. Maria Fedchuk’s contributions to aesthetic medicine, including the award-winning PEELING SYSTEM and FDA-approved technologies
Episode Transcript
A groundbreaking event recently took place at the 22nd Aesthetic & Anti-Aging Medicine World Congress in Monaco, Monte-Carlo, where Dr. Maria Fedchuk introduced the innovative EXOSOMAL LIQUID LASER technology. This advanced treatment protocol involves a unique blend of acids, microneedling, and exosomes to achieve remarkable skin transformation within just six days. The technology is centered around exosomes, tiny vesicles that excel in skin regeneration and tackling issues like wrinkles, acne, and scars.
Dr. Maria Fedchuk, a fourth-generation physician and eminent dermatologist from Ukraine, has significantly advanced the aesthetic medical field with over 18 years of experience. Her contributions were also spotlighted with the award-winning PEELING SYSTEM, which received international acclaim for its exceptional results and integration with aesthetic products.
Dr. Fedchuk’s company, Medical Tech Systems US, continues to bring revolutionary developments to the American market, ensuring that patient safety remains paramount. The approval of her technologies by the FDA underscores their safety, effectiveness, and cutting-edge innovation.
On this August 20, 2024, it’s exciting to witness how these advancements are set to transform aesthetic medicine globally.
